Market Overview

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)

83.40 +0.49 (0.60%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/27/17BMO CapitalMaintainsOutperform119.0
10/27/17Stifel NicolausMaintainsBuy105.0
10/19/17Leerink SwannMaintainsOutperform142.0
10/19/17Credit SuisseMaintainsOutperform124.0
10/06/17Morgan StanleyMaintainsOverweight117.0
9/15/17RBC CapitalInitiates Coverage OnSector Perform93.0
9/14/17PiperJaffrayAssumesOverweight0.0
8/17/17Evercore ISI GroupInitiates Coverage OnOutperform0.0
7/27/17BernsteinInitiates Coverage OnMarket Perform89.0
3/30/17UBSInitiates Coverage OnNeutral92.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter